Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Martin

Showing results (281-290 of 320) with videos related to

Pageof 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibodyO W Press, J F Eary, C C Badger, et al.
Bone Marrow Transplantation|September 12, 2000
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experienceJ Sierra, B Storer, J A Hansen, et al.
Lancet (London, England)|August 5, 1995
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomasO W Press, J F Eary, F R Appelbaum, et al.
Cancer Research|February 1, 1990
High dose radiolabeled antibody therapy of lymphomaI D Bernstein, J F Eary, C C Badger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
T cells specific for a polymorphic segment of CD45 induce graft-versus-host disease with predominant pulmonary vasculitisW Chen, G S Chatta, W D Rubin, et al.
Blood|December 12, 2001
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studiesG Socié, R A Clift, D Blaise, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2019
NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cellsMaureen Keller, Fatéméh Dubois, Sylvain Teulier, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Blood|December 1, 1988
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission durationP J Martin, R A Clift, L D Fisher, et al.
Transplantation|February 1, 1991
Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignanciesP G Beatty, J A Hansen, G M Longton, et al.
Pageof 32

Showing results (281-290 of 320) with videos related to

Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibodyO W Press, J F Eary, C C Badger, et al.
Bone Marrow Transplantation|September 12, 2000
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experienceJ Sierra, B Storer, J A Hansen, et al.
Lancet (London, England)|August 5, 1995
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomasO W Press, J F Eary, F R Appelbaum, et al.
Cancer Research|February 1, 1990
High dose radiolabeled antibody therapy of lymphomaI D Bernstein, J F Eary, C C Badger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 1998
T cells specific for a polymorphic segment of CD45 induce graft-versus-host disease with predominant pulmonary vasculitisW Chen, G S Chatta, W D Rubin, et al.
Blood|December 12, 2001
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studiesG Socié, R A Clift, D Blaise, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 14, 2019
NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cellsMaureen Keller, Fatéméh Dubois, Sylvain Teulier, et al.
Blood|December 12, 2001
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trialE Kansu, T Gooley, M E Flowers, et al.
Blood|December 1, 1988
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission durationP J Martin, R A Clift, L D Fisher, et al.
Transplantation|February 1, 1991
Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignanciesP G Beatty, J A Hansen, G M Longton, et al.
Pageof 32